7-10990742-C-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001007157.2(PHF14):c.940C>A(p.Gln314Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,564,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )
Consequence
PHF14
NM_001007157.2 missense
NM_001007157.2 missense
Scores
1
7
10
Clinical Significance
Conservation
PhyloP100: 7.85
Genes affected
PHF14 (HGNC:22203): (PHD finger protein 14) Predicted to enable histone binding activity. Predicted to be involved in histone H3-K14 acetylation and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including lung alveolus development; negative regulation of mesenchymal cell proliferation involved in lung development; and negative regulation of platelet-derived growth factor receptor-alpha signaling pathway. Predicted to be located in nucleus. Predicted to be part of MOZ/MORF histone acetyltransferase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23304081).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHF14 | NM_001007157.2 | c.940C>A | p.Gln314Lys | missense_variant | 4/18 | ENST00000634607.2 | NP_001007158.1 | |
PHF14 | NM_014660.4 | c.940C>A | p.Gln314Lys | missense_variant | 4/17 | NP_055475.2 | ||
PHF14 | NR_033435.2 | n.604C>A | non_coding_transcript_exon_variant | 3/16 | ||||
PHF14 | NR_033436.2 | n.604C>A | non_coding_transcript_exon_variant | 3/17 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000462 AC: 7AN: 151574Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
151574
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000375 AC: 7AN: 186830Hom.: 0 AF XY: 0.0000606 AC XY: 6AN XY: 99088
GnomAD3 exomes
AF:
AC:
7
AN:
186830
Hom.:
AF XY:
AC XY:
6
AN XY:
99088
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000107 AC: 151AN: 1413298Hom.: 0 Cov.: 27 AF XY: 0.0000930 AC XY: 65AN XY: 699220
GnomAD4 exome
AF:
AC:
151
AN:
1413298
Hom.:
Cov.:
27
AF XY:
AC XY:
65
AN XY:
699220
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000462 AC: 7AN: 151574Hom.: 0 Cov.: 32 AF XY: 0.0000676 AC XY: 5AN XY: 73962
GnomAD4 genome
AF:
AC:
7
AN:
151574
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
73962
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.940C>A (p.Q314K) alteration is located in exon 4 (coding exon 4) of the PHF14 gene. This alteration results from a C to A substitution at nucleotide position 940, causing the glutamine (Q) at amino acid position 314 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;L;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N;.
REVEL
Benign
Sift
Benign
.;T;.
Polyphen
P;P;.
Vest4
0.64, 0.71
MutPred
0.45
.;Gain of methylation at Q314 (P = 0.0067);Gain of methylation at Q314 (P = 0.0067);
MVP
0.35
MPC
0.059
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at